Genetic
Multi-omics Analysis
Multi-omics Analysis is a genetic therapy with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Other(1)
Detailed Status
Not yet recruiting2
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown125%
not_yet_recruiting250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruiting
Pilot Study of Discarded Blastocysts
NCT07429097
not_yet_recruiting
Omics of Rituximab-resistance
NCT07416942
recruiting
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605
unknownnot_applicable
Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques
NCT05090553
Clinical Trials (4)
Showing 4 of 4 trials
NCT07429097
Pilot Study of Discarded Blastocysts
NCT07416942
Omics of Rituximab-resistance
NCT05636605
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05090553Not Applicable
Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques
All 4 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 4